Let’s look at the key reasons that are pushing Geron Corp (GERN) to new highs

On Friday, Geron Corp (NASDAQ: GERN) opened lower -1.20% from the last session, before settling in for the closing price of $4.17. Price fluctuations for GERN have ranged from $1.64 to $5.34 over the past 52 weeks.

Healthcare Sector giant saw their annual sales surged by 46.26% over the last five years. Company’s average yearly earnings per share was noted 18.23% at the time writing. With a float of $564.54 million, this company’s outstanding shares have now reached $604.50 million.

The firm has a total of 141 workers. Let’s measure their productivity. In terms of profitability, gross margin is 96.53%, operating margin of -705.46%, and the pretax margin is -682.48%.

Geron Corp (GERN) Breakdown of a Key Holders of the stock

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Geron Corp is 6.61%, while institutional ownership is 78.63%. The most recent insider transaction that took place on Jul 08 ’24, was worth 3,073,004. In this transaction EVP, Chief Operating Officer of this company sold 674,348 shares at a rate of $4.56, taking the stock ownership to the 0 shares. Before that another transaction happened on Jun 10 ’24, when Company’s EVP, Chief Medical Officer sold 287,900 for $4.63, making the entire transaction worth $1,334,129. This insider now owns 0 shares in total.

Geron Corp (GERN) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 18.23% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.00% during the next five years compared to -16.08% drop over the previous five years of trading.

Geron Corp (NASDAQ: GERN) Trading Performance Indicators

Check out the current performance indicators for Geron Corp (GERN). In the past quarter, the stock posted a quick ratio of 2.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 83.47.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.32, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.07 in one year’s time.

Technical Analysis of Geron Corp (GERN)

Analysing the last 5-days average volume posted by the [Geron Corp, GERN], we can find that recorded value of 5.66 million was lower than the volume posted last year of 10.35 million. As of the previous 9 days, the stock’s Stochastic %D was 91.46%. Additionally, its Average True Range was 0.19.

During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 35.62%, which indicates a significant decrease from 79.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.98% in the past 14 days, which was lower than the 45.76% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $4.17, while its 200-day Moving Average is $3.94. Now, the first resistance to watch is $4.20. This is followed by the second major resistance level at $4.28. The third major resistance level sits at $4.36. If the price goes on to break the first support level at $4.04, it is likely to go to the next support level at $3.96. Now, if the price goes above the second support level, the third support stands at $3.88.

Geron Corp (NASDAQ: GERN) Key Stats

There are currently 604,501K shares outstanding in the company with a market cap of 2.46 billion. Presently, the company’s annual sales total 240 K according to its annual income of -184,130 K. Last quarter, the company’s sales amounted to 28,270 K and its income totaled -26,450 K.